                         SEQUENCE LISTING

<110>  CHILDREN'S HOSPITAL MEDICAL CENTER, et al.
 
<120>  COMPOSITIONS AND METHODS FOR TREATMENT OF AN ABNORMAL IMMUNE RESPONSE VIA GSK INHIBITION

<130>  0663627

<150>  US 62/537,092
<151>  2017-07-26

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MYC, Forward

<400>  1
atgcccctca acgtgaactt c                                                 21


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MYC, Reverse

<400>  2
gtcgcagatg aaatagggct g                                                 21


<210>  3
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  wnt3a, Forward

<400>  3
ctcctctcgg atacctctta gtg                                               23


<210>  4
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  wnt3a, Reverse

<400>  4
ccaaggacca ccagatcgg                                                    19


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ctnnb1, Forward

<400>  5
atggagccgg acagaaaagc                                                   20


<210>  6
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ctnnb1, Reverse

<400>  6
cttgccactc agggaagga                                                    19


<210>  7
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  L32, Forward

<400>  7
gaaactggcg gaaaccca                                                     18


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  L32, Reverse

<400>  8
ggatctggcc cttgaacctt                                                   20


